Skip to main content
. 2020 Aug 27;41(1):72–135. doi: 10.1002/med.21724

Figure 18.

Figure 18

Peptidomimetic SARS‐CoV‐2 Mpro inhibitors with P3‐indole moiety. Mpro, main protease; SARS‐CoV, severe acute respiratory syndrome coronavirus